NCT01184417

Phenobarbital for Acute Alcohol Withdrawal

Phenobarbital Versus Placebo for Acute Alcohol Withdrawal

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 102 (actual)
• Sponsor: Jonathan Rosenson · Academic / Other
• Sex: All
• Age: 18 Years – 65 Years
• Healthy volunteers: Not accepted

Summary

Intravenous phenobarbital in combination with a symptom-guided standardized lorazepam-based alcohol withdrawal protocol will be associated with decreased need for ICU admission, continuous lorazepam infusion and will not be associated with increased adverse events.

Conditions

• Alcohol Withdrawal

Interventions

Type	Name	Description
DRUG	10 mg/kg IV phenobarbital in 100 ml saline	10 mg/kg IV phenobarbital in 100 ml saline
DRUG	placebo	100 m l saline

Timeline

• Start date: 2009-01-01
• Primary completion: 2010-03-01
• Completion: 2010-03-01
• First posted: 2010-08-19
• Last updated: 2012-03-09
• Results posted: 2012-03-09

Locations

1 site across 1 country: United States